Design approaches to drug discovery: Difference between revisions
From Crucible Network Research Projects
Jump to navigationJump to search
(Created page with "A series of projects commissioned by pharmaceutical company ArQule explored the potential for visualisation of probability spaces resulting from quantum simulation of drug compou...") |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
A series of projects commissioned by pharmaceutical company ArQule explored the potential for visualisation of probability spaces resulting from quantum simulation of drug compound behaviours, combining these with a sociological exploration of the laboratories within such data was used. The results were developed through an interaction design process into products that continue to be influential, most recently in the foundation of Cambridge company Optibrium by members of the team. | A series of projects commissioned by pharmaceutical company [[ArQule]] (originally for the startup company [[Camitro]], acquired by ArQule in the course of the work) explored the potential for visualisation of probability spaces resulting from quantum simulation of drug compound behaviours, combining these with a sociological exploration of the laboratories within such data was used. The results were developed through an interaction design process into products that continue to be influential, most recently in the foundation of Cambridge company [[Optibrium]] by members of the team. | ||
Crucible collaborators: | Crucible collaborators: | ||
| Line 10: | Line 10: | ||
* [[Andrew Barry]] | * [[Andrew Barry]] | ||
* [[Georgina Born]] | * [[Georgina Born]] | ||
* [[Janine Tolliday]] | |||
* [[Michael Tarbit]] | |||
[[Category:Projects]] | |||
Latest revision as of 16:38, 1 September 2011
A series of projects commissioned by pharmaceutical company ArQule (originally for the startup company Camitro, acquired by ArQule in the course of the work) explored the potential for visualisation of probability spaces resulting from quantum simulation of drug compound behaviours, combining these with a sociological exploration of the laboratories within such data was used. The results were developed through an interaction design process into products that continue to be influential, most recently in the foundation of Cambridge company Optibrium by members of the team.
Crucible collaborators:
